If a combination therapy achieves a better result than a monotherapy then surely this is something worth pursuing. Typical bowel cancer therapy is radiation plus chemo. Being an experimental drug we have nothing to lose by engaging in more trials at minimal cost.
- Forums
- ASX - By Stock
- KZA
- Ann: paxalisib PNOC collaboration
Ann: paxalisib PNOC collaboration, page-16
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)